Table 4 The Post-hoc analysis (least significant difference) comparing IGFBP-3 serum levels for each of the 6 CVMI stages
From: Serum IGF-1, IGFBP-3 and their ratio: Potential biochemical growth maturity indicators
CVMI Stage | CVMI stage | Mean Difference | Significance |
|---|---|---|---|
1 | 2 | -516.1 | 0.240(NS) |
3 | -1896.9* | 0.000(**) | |
4 | -2130.8* | 0.000(**) | |
5 | -928.1* | 0.036(*) | |
6 | -543.5 | 0.216(NS) | |
2 | 1 | 516.1 | 0.240(NS) |
3 | -1380.8* | 0.002(**) | |
4 | -1614.6* | 0.000(**) | |
5 | -411.9 | 0.347(NS) | |
6 | -27.4 | 0.950(NS) | |
3 | 1 | 1896.9* | 0.000(**) |
2 | 1380.8* | 0.002(**) | |
4 | -233.8 | 0.593(NS) | |
5 | 968.8* | 0.029(**) | |
6 | 1353.4* | 0.003(**) | |
4 | 1 | 2130.8* | 0.000(**) |
2 | 1614.6* | 0.000(**) | |
3 | 233.8 | 0.593(NS) | |
5 | 1202.7* | 0.007(**) | |
6 | 1587.2* | 0.000(**) | |
5 | 1 | 928.1* | 0.036(*) |
2 | 411.9 | 0.347(NS) | |
3 | -968.8* | 0.029(*) | |
4 | -1202.7* | 0.007(**) | |
6 | 384.5 | 0.380(NS) | |
6 | 1 | 543.5 | 0.216(NS) |
2 | 27.4 | 0.950(NS) | |
3 | -1353.4* | 0.003(**) | |
4 | -1587.2* | 0.000(**) | |
5 | -384.5 | 0.380(NS) |